July 02, 2025CorporateTERUMO ANNOUNCES COMMERCIAL LAUNCH OF THE IMMUCISE™ INTRADERMAL INJECTION SYSTEM
Site Map Show — Site Map Hide — Site Map What’s new News Press Inquiries About Terumo Dear Stakeholders Group Mission Who We Are Corporate Governance Compliance Regulations and Standards Procurement Activity At a Glance Leadership Team History Brand Video "Our Promise" Terumo's Response to COVID-19 Education and Training Terumo Ventures Business Overview Terumo Interventional Systems Terumo Neuro Terumo Cardiovascular / HeartSheet Division Terumo Aortic Hospital Care Solutions Life Care Solutions Pharmaceutical Solutions Terumo Blood and Cell Technologies Company (Terumo Blood and Cell Technologies) Sustainability Sustainability News Sustainability at the Terumo Group GRI Standards Index Technology From Devices to Solutions Special Movies “Our Solutions” Terumo’s strengths—the 3Ds The Solutions Terumo Aims for Basic Information Research and Development Production and Supply Intellectual Property Investors Management Policy Management Policy Top Management Message Business Risks Disclaimer IR Policy IR Library Financial Statements Presentations Terumo Reports Terumo Report (online version) IR Events IR Inquiries Financial Highlights Shareholders & Stock Shareholders Meeting Stock Information Shareholder Return Credit Ratings and Corporate Bond Analyst Coverage Articles of Incorporation Site Quote Terms and Conditions of Use Privacy Policy Social Media Policy
Top
Top